热门资讯> 正文

Veraderspel报告第二季度业绩

2026-08-11 19:36

Veradermics(MANE) 0
VDO-PH INTL(VDPH) 0

Veradermics press release (MANE): Q2 Net loss was $23.5 million as compared to a net loss of $15.6 million for the second quarter of 2025.
Cash, cash equivalents and marketable securities of $819.9 million as of June 30, 2026, expected to fund operations into 2030 through multiple Phase 3 readouts and potential commercial launch of VDPHL01.

More on Veradermics

Veradermics: Wait For The Post-Lockup, But Buy Before The Roll-Up
Veradermics, Incorporated (MANE) Discusses Positive Female Results From Phase II Study of VDPHL01 for Pattern Hair Loss - Slideshow
Veradermics: VDPHL01 Looks Promising Enough On Paper
Veradermics jumps after mid-stage trial data for lead drug in female pattern hair loss
Historical earnings data for Veradermics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。